Immunologic alterations in bleomycin-treated mice: Role of pulmonary fibrosis in the modulation of immune responses

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1924-1930

  Zhu, Jian ^a   Kaplan, Alan M ^a   Goud, S Niranjan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG FIBROSIS; LYMPHOMA; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0029948608     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665057     Document Type: Article

References (33)

1. Haskell, C. M. 1990. Drugs used in Cancer Chemotherapy. In C. M. Haskell, editor. Cancer Treatment. W. B. Saunders, Philadelphia. 63-65.
2. Ginsberg, S. J., and R. L. Comis. 1982. The pulmonary toxicity of anti-neoplastic agents. Semin. Oncol. 9:34-51.
3. Thrall, R. S., J. R. McCormick, R. M. Jack, R. A. McReynolds, and P. A. Ward. 1979. Bleomycin induced pulmonary fibrosis in the rat. Am. J. Pathol. 95:117-127.
4. Thrall, R. S., E. J. Lovett, R. W. Barton, J. R. McCormick, S. H. Phan, and P. A. Ward. 1980. The effect of T cell depletion on the development of bleomycin induced pulmonary fibrosis in the rat (abstract). Am. Rev. Respir. Dis. 121:99.
5. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
6. Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin induced pulmonary fibrosis. Exp. Lung Res. 18:29-43.
7. Khalil, N., D. Bereznay, M. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
8. Hoyt, D. G., and J. S. Lazo. 1988. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-β precede bleomycin induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 26:765-771.
9. Schrier, D. J., S. H. Phan, and B. M. McGarry. 1983. The effects of nude (nu/nu) mutation on bleomycin induced pulmonary fibrosis. A biochemical evaluation. Am. Rev. Respir. Dis. 127:614-617.
10. Szapiel, S. V., N. A. Elson, J. D. Fulmer, G. W. Hunninghake, and R. G. Crystal. 1979. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis. 120:893-899.
11. Stein-Streilein, J., M. F. Lipscomb, H. Fisch, and P. L. Whitney. 1987. Pulmonary interstitial fibrosis induced in hapten immune hamsters. Am. Rev. Respir. Dis. 136:119-123.
12. + T lymphocytes. J. Leukocyte Biol. 54:414-422.
13. Witschi, H. P., A. F. Tryka, and R. C. Lindenschmidet. 1985. The many facets of an increase in lung collagen. Fundam. Appl. Toxicol. 5: 240-250.
14. Goud, S. N., A. M. Kaplan, and B. Subbarao. 1992. Effects of cigarette smoke on the antibody responses to thymic independent antigens from different lymphoid tissues of mice. Arch. Toxicol. 66: 164-169.
15. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: Parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032.
16. Goud, S. N., L. Zhang, and A. M. Kaplan. 1993. Immunostimulatory potential of smokeless tobacco extract in in vitro cultures of murine lymphoid tissues. Immunopharmacology 25:95-105.
17. Adamson, Y. R., and D. H. Bowden. 1974. The pathogenesis of bleomycin induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185-190.
18. Janick Buckner, D., G. E. Ranges, and M. P. Hacker. 1989. Alteration of bronchoalveolar lavage cell populations following bleomycin treatment. Toxicol. Appl. Pharmacol. 100:465-473.
19. Karpel, J. P., T. K. Aldrich, S. Mitsudo, and A. J. Norin. 1989. Lung lymphocytes in bleomycin induced pulmonary disease. Lung 167: 163-172.
20. Lazo, J. S., and C. J. Humphreys. 1983. Lack of metabolism as the biochemical basis of bleomycin induced pulmonary toxicity. Proc. Natl. Acad. Sci. U.S.A. 80:3064-3068.
21. Chandra, R. K., and S. Kumari. 1994. Nutrition and immunity: an overview. J. Nutr. 124:1433S-1435S.
22. Bartlett, W. C., A. Purchio, H. P. Fell, and R. J. Noelle. 1991. Cognate interactions between T cells and B cells. VI. TGF-β inhibits B cell activation and antigen specific physical interactions between Th and B cells. Lymphokine Cytokine Res. 10:177-183.
23. Janssen, O., and D. Kabelitz. 1988. Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus. J. Immunol. 140:125-130.
24. Wahl, S. M., D. A. Hunt, H. L. Wong, S. Dougherty, N. McCartney-Francis, L. M. Wahl, L. Ellingsworth, J. A. Schmidt, G. Hall, A. B. Roberts, and A. B. Sporn. 1988. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation. J. Immunol. 140:3026-3032.
25. Kashiwa, H., S. C. Wright, and B. Bonavida. 1987. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen induced B cell differentiation by tumor necrosis factor (TNF). J. Immunol. 138:1383-1390.
26. Fireman, E., S. Ben-Efraim, S. Spinrad, M. Topilsky, and J. Greif. 1993. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. Eur. Respir. J. 6:956-964.
27. Giri, S. N., J. M. Nakashima, and D. L. Curry. 1985. Effects of intratracheal administration of bleomycin or saline in pair-fed and control fed hamsters on daily food intake and on plasma levels of glucose, cortisol, insulin and lung levels of calmodulin, calcium and collagen. Exp. Mol. Pathol. 42:206-219.
28. Gillis, S., G. R. Crabtree, and K. Smith. 1979. Glucocorticoid induced inhibition of T-cell growth factor production. I. The effect on mitogen induced lymphocyte proliferation. J. Immunol. 123:1624-1631.
29. Ranelletti, F. O., P. Musiani, N. Maggiano, L. Lauriola, and M. Piantelli. 1983. Modulation of glucocorticoid inhibition action on human lymphocyte mitogenesis: dependence on mitogen concentration and T cell maturity. Cell. Immunol. 76:22-28.
30. Vasilomanolakis, E. C., and N. M. Goldberg. 1993. Bepridil induced pulmonary fibrosis. Am. Heart J. 126:1016-1017.
31. Dubaybo, B. A. 1986. That, changes in lung tissues and lavage fibronectin after paraquat injury in rats. Res. Commun. Chem. Pathol. Pharmacol. 51:211-220.
32. Gilligan, P. H. 1991. Microbiology of airway diseases in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
33. Stover, D. E., D. A. White, P. A. Romano, R. A. Gellene, and W. A. Robeson. 1985. Spectrum of pulmonary diseases associated with the acquired immunodeficiency syndrome. Am. J. Med. 78:429-437.